Vestmark Advisory Solutions’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,858
| Closed | -$327K | – | 811 |
|
|
2023
Q2 | $327K | Hold |
2,858
| – | – | 0.01% | 691 |
|
|
2023
Q1 | $394K | Sell |
2,858
-30
| -1% | -$4.14K | 0.02% | 626 |
|
|
2022
Q4 | $374K | Sell |
2,888
-545
| -16% | -$70.6K | 0.02% | 626 |
|
|
2022
Q3 | $379K | Sell |
3,433
-1,374
| -29% | -$152K | 0.02% | 602 |
|
|
2022
Q2 | $360K | Sell |
4,807
-1,163
| -19% | -$87.1K | 0.02% | 620 |
|
|
2022
Q1 | $466K | Sell |
5,970
-969
| -14% | -$75.6K | 0.03% | 560 |
|
|
2021
Q4 | $625K | Hold |
6,939
| – | – | 0.04% | 472 |
|
|
2021
Q3 | $642K | Buy |
6,939
+577
| +9% | +$53.4K | 0.04% | 431 |
|
|
2021
Q2 | $495K | Buy |
6,362
+390
| +7% | +$30.3K | 0.04% | 479 |
|
|
2021
Q1 | $445K | Buy |
+5,972
| New | +$445K | 0.04% | 470 |
|